These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1087232)
1. Influence of different cytotoxic drugs on T and B lymphocytes in children with all during remission maintenance therapy. Ritter J; Oehme J Eur J Pediatr; 1976 Dec; 124(1):37-42. PubMed ID: 1087232 [TBL] [Abstract][Full Text] [Related]
2. T and B lymphocytes in leukemia therapy. Esber E; DiNicola W; Movassaghi N; Leikin S Am J Hematol; 1976; 1(2):211-8. PubMed ID: 1087115 [TBL] [Abstract][Full Text] [Related]
3. Influence of prednisone and cytostatics on human blood B-, T- and O-lymphocytes in diseases. Jonsson V Scand J Haematol; 1975 Sep; 15(2):109-16. PubMed ID: 1081272 [TBL] [Abstract][Full Text] [Related]
4. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy]. Kaftański R Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275 [TBL] [Abstract][Full Text] [Related]
5. [T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)]. Wehinger H; Karitzky D Klin Padiatr; 1977 May; 189(3):234-41. PubMed ID: 301585 [TBL] [Abstract][Full Text] [Related]
6. [Lymphocyte subpopulations in acute lymphoblastic leukemia in children]. Schneer JH; Mănăliă T; Dimitriu AG Rev Pediatr Obstet Ginecol Pediatr; 1978; 27(2):169-75. PubMed ID: 96512 [No Abstract] [Full Text] [Related]
7. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission]. Beck ID; Lemmel EM Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527 [No Abstract] [Full Text] [Related]
8. Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy. MacLennan IC; Kay HE; Festenstein M; Smith PG Br J Haematol; 1976 Jun; 33(2):179-88. PubMed ID: 1063593 [TBL] [Abstract][Full Text] [Related]
9. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials. Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961 [TBL] [Abstract][Full Text] [Related]
10. [Changes in blood lymphocytes and their subpopulation in patients with myeloblastic leukemia treated with cytostatic agents]. Urasiński I; Proniewska M; Schumacher K Acta Haematol Pol; 1979; 10(2):129-36. PubMed ID: 314215 [TBL] [Abstract][Full Text] [Related]
11. Immunocompetence and prognosis in children with acute lymphoblastic leukemia: combination of two different maintenance therapies. Garay GE; Pavlovsky S; Sasiain MC; Pizzolato MA; Binsztein N; Eppinger-Helft M Med Pediatr Oncol; 1976; 2(4):403-15. PubMed ID: 1069898 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia. Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296 [TBL] [Abstract][Full Text] [Related]
14. The study of T-, B-, O- lymphocytes in acute lymphoblastic leukemia. Bogusławska-Jaworska J; Chybicka A Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):859-66. PubMed ID: 312091 [TBL] [Abstract][Full Text] [Related]
15. Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages. Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RA; Schretlen ED Biochem Pharmacol; 1988 Jun; 37(12):2321-7. PubMed ID: 2455519 [TBL] [Abstract][Full Text] [Related]
16. Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia. Nielsen SN; Grell K; Nersting J; Frandsen TL; Hjalgrim LL; Schmiegelow K Cancer Chemother Pharmacol; 2016 Nov; 78(5):983-994. PubMed ID: 27600880 [TBL] [Abstract][Full Text] [Related]
17. [In vitro study of sensitivity of leukemic cells to cytotoxic drugs (anticytogram)]. Zittoun R; Bouchard M; Facquet-Danis J; Diaz-Mayo C; Percie-du-Sert M; Bousser J Nouv Presse Med; 1975 Feb; 4(6):401-4. PubMed ID: 1055355 [TBL] [Abstract][Full Text] [Related]
18. Studies on the immune status of children with acute lymphocytic leukaemia. II. In remission with and without cytostatic treatment. Hitzig WH; Plüss HJ; Joller P; Pilgrim U; Tacier-Eugster H; Jakob M Clin Exp Immunol; 1976 Dec; 26(3):414-8. PubMed ID: 1087594 [TBL] [Abstract][Full Text] [Related]
19. [The Munich study on the treatment of acute lymphoblastic leukemia in childhood (ALL 77-02)]. Graubner UB; Haas RJ; Janka G; Gaedicke G; Kohne E; Rieber EP Klin Padiatr; 1985; 197(3):207-14. PubMed ID: 3892149 [TBL] [Abstract][Full Text] [Related]
20. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group. Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]